Potassium Channels

Chlorpromazine is an orally active antipsychotic agent that primarily antagonizes D2 dopamine and 5-HT2A serotonin receptors, making it effective in the treatment of schizophrenia and other psychiatric conditions. Additionally, chlorpromazine exhibits anti-cancer properties through mechanisms such as inhibition of tumor proliferation, induction of autophagy, cell cycle arrest at the G2-M phase, and suppression of tumor growth and metastasis. It also blocks hNav1.7 and HERG potassium channels, which has implications for analgesic and cardiac arrhythmia research. Furthermore, chlorpromazine inhibits clathrin-mediated endocytosis, expanding its potential applications in biomedical research.